Evidence map›Paper›PMID 41509406›Full record

ArticlebioRxiv : the preprint server for biology2026

De novo design of protein nanoparticles with integrated functional motifs.

Cyrus M Haas, Sanela Rankovic, Hanul K Lewis, Kenneth D Carr, Connor Weidle, Sophie S Gerdes, Lily R Nuss, Felicitas Ruiz, Syed Moiz, Maggie Fiorelli and 16 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Cyrus M HaasDepartment of Chemical Engineering, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-2204-9847
Sanela RankovicInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0001-9448-6037
Hanul K LewisInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0009-0003-0488-2119
Kenneth D CarrInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0009-0005-1929-3952
Connor WeidleInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-9354-2276
Sophie S GerdesInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0009-0004-3147-8944
Lily R NussInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0009-0009-0821-7048
Felicitas RuizInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0003-2175-0356
Syed MoizInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Maggie FiorelliInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-4793-3890
Emily GreyInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0003-1153-7471
Jackson McGowanInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0009-0002-6418-3371
Nikhila KumarVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892.
Adrian CreangaVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892.
Alex KangInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0001-5487-0499
Hannah NguyenInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0001-9696-4004
Yanqing WangInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0009-0000-2223-2687
Banumathi SankaranMolecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Annie DoseyInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0001-6858-4725
Rashmi RavichandranInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-2630-7487
Asim K BeraInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0001-9473-2912
Elizabeth M LeafInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-5354-6010
Cole A DeForestDepartment of Chemical Engineering, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0003-0337-3577
Masaru KanekiyoVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892.ORCID 0000-0001-5767-1532
Andrew J BorstInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0003-4297-7824
Neil P KingInstitute for Protein Design, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-2978-4692

Funding

Project 5: mRNA and mRNA-launched nanoparticle vaccinesU19AI181881 · NIAID · UNIVERSITY OF WASHINGTON · PI KING, NEIL, STUART, LYNDA · 2024 to 2024
$41.1M
X-ray Scattering Technology CoreP30GM133893 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI Lin Yang · 2019 to 2026
$38.6M
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral DynamicsU54AI170856 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI WALTHER H MOTHES · 2022 to 2026
$34.4M
Structure-based design of broadly protective coronavirus vaccinesP01AI167966 · NIAID · UNIVERSITY OF WASHINGTON · PI Neil King, David Veesler · 2022 to 2026
$15.3M
NIAID NIH HHS P01 AI167966NIAID NIH HHS U19 AI181881NIAID NIH HHS U54 AI170856NIGMS NIH HHS P30 GM133893
6 · The paper itself

Abstract

Computational design of self-assembling proteins has long relied on pre-existing structures and sequences, fundamentally limiting control over their structural and functional properties. Recent machine learning-based methods have transformed our ability to design functional small de novo proteins and oligomers, yet methods to design large de novo protein assemblies with structures tailored to specific applications are still underexplored. Here, we develop a generalizable method for designing de novo symmetric protein complexes that incorporate target functional motifs into their structures. We report 34 new protein nanoparticles that form on-target assemblies with cubic point group symmetries. The nanoparticles exhibit a wide variety of backbones that were designed with atom-level accuracy, as evidenced by several cryo-EM and crystal structures that reveal minimal deviations from the design models. We use the method to generate a de novo antigen-tailored nanoparticle vaccine that elicits robust immune responses in mice. These results establish a generalizable approach that can be used to design functional self-assembling protein complexes with structures tailored to specific applications.

Identifiers

PMID41509406
PMCPMC12776285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.